Abstract
Two estrogen receptors (ER), ERα and ERβ, are expressed in breast cancer but their role in treatment response is unclear. The overall objective of this study was to determine if the presence of ERβ protein in breast cancer cell lines is an indicator of a poor prognosis based on cell proliferation. In addition, we determined the effect of estradiol (E2) and selective estrogen receptor modulators (SERMs), such as tamoxifen and genistein, on ERα and ERβ protein regulation, to help in the understanding of the mechanism behind their role in modulating cell proliferation. Using western blot and immunofluorescence analysis, the ER positive cell lines, MCF-7 and T47D, were found to contain both ERα and ERβ, and thus were used as model systems. E2 and genistein, which increased cell proliferation in both cell lines, induced an up regulation of ERβ in both cell lines. This suggests that an estrogenic response in breast cancer cells is indicated by an increase in ERβ expression. Tamoxifen decreased cell proliferation in both cell lines, while up regulating ERα in both cell lines, suggesting that antiestrogenic response is indicated by an increase in ERα expression. Although a change in the ERα/ERβ ratio may play a role in the effect seen in cell proliferation, this study indicates that ERβ is a poor prognosticator of cell proliferation in breast cancer and that ERα is a positive prognosticator of responsiveness to antiestrogen treatment.
Similar content being viewed by others
References
Lawrence J, Malpas P, Sigman C, Kelloff G: Clinical development of estrogen modulators for breast cancer chemoprevention in premenopausal v.s. postmenopausal women. J Cell Biochem S34: 103–114, 2000
Casanova M, You L, Gaido K, Archibeque-Engle S, Janszen D, Heck H: Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daizein with rat ERα and ERβ in vitro. Toxicol Sci 51: 236–244, 1999
Jordan V: Molecular mechanisms of antiestrogen action in breast cancer. Breast Cancer Res Treat 31: 41–52, 1994
Russo J, Ao X, Grill C, Russo I: Pattern of distribution of cells positive for estrogen receptor α and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 53: 217–227, 1999
Goodson W, Moore D, Ljung B, Chew K, Mayall B, Smith H, Waldman F: The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67. Breast Cancer Res Treat 59: 113–123, 2000
Wiesen J, Young P, Werb Z, Cunha G: Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 126: 335–344, 1999
Kuiper G, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925–5930, 1996
Osborne K: Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 51: 227–238, 1998
Pavao M, Traish A: Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor α and β. Steroid 66: 1–16, 2001
Pettersson K, Delaunay F, Gustafsson J: Estrogen receptor β acts as a dominant regulator of estrogen signaling. Oncogene 19: 4970–4978, 2000
Jensen E, Cheng G, Palmieri C, Saji S, Mäkelä S, Van Noorden S, Wahlström T, Warner M, Coombes R, Gustafsson J: Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci USA 98: 15197–15202, 2001
Paech K, Webb P, Kuiper G, Nilsson S, Gustafsson J, Kushner P, Scanlan T: Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277: 1508–1510, 1997
Speirs V, Parkes A, Kerin M, Walton D, Carleton P, Fox J, Atkin S: Coexpression of estrogen receptor α and β: poor prognostic factors in human breast cancer? Cancer Res 59: 525–528, 1999
Neven P, Vergote I: Tamoxifen, screening and new oestrogen receptor modulators. Best Prac Res Cl Ob 15: 365–380, 2001
Fabian C: Who should receive which selective estrogen receptor modulator for prevention of breast cancer. Breast J 5: 211–214, 1999
McInerney E, Weis K, Sun J, Mosselman S, Katzenellenbogen B: Transcription activation by the human estrogen receptor subtype β (ERβ) studied with ERβ and ERα receptor chimeras. Endocrinology 139: 4513–4522, 1998
Speirs V, Malone C, Walton D, Kerin M, Atkin S: Increased expression of estrogen receptor beta mRNA in tamoxifenresistant breast cancer patients. Cancer Res 59: 5421–5424, 1999
Barnes S, Grubbs C, Setchell K, Carlson J: Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res 347: 239–253, 1990
Messina M, Loprinzi C: Soy for breast cancer survivors: a critical review of the literature. J Nutr 131: 3095S–3108S, 2001
Allred C, Allred K, Ju Y, Virant S, Helferich W: Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose dependent manner. Cancer Res 61: 5045–5050, 2001
Hsieh C, Santell R, Haslam S, Helferich W: Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58: 3833–3838, 1998
Zava D, Duwe G: Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27: 31–40, 1997
Wang T, Sathyamoorthy N, Phang J: Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17: 271–275, 1996
Kuiper G, Lemmen J, Carlsson B, Corton J, Safe S, van der Saag P, van der Burg B, Gustafsson J: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139: 4252–4263, 1998
Vladusic E, Hornby A, Guerra-Vladusic F, Lakins J, Lupu R: Expression and regulation of estrogen receptor β in human breast tumors and cell lines. Oncol Rep 7: 157–167, 2000
Palmieri C, Cheng G, Saji S, Zelada-Hedman M, Warri A, Weihua Z, Noorden S, Wahlstrom T, Coombes R, Warner, Gustafsson J: Estrogen receptor beta in breast cancer. Endocr-Relat-Cancer 9: 1–13, 2002
Gustafsson J, Warner M: Estrogen receptor β in the breast: role in estrogen responsiveness and development of breast cancer. J Steroid Biochem Mol Biol 74: 245–248, 2000
Jarvinen T, Pelto-Huikko M, Holli K, Isola J: Estrogen receptor beta is coexpressed with estrogen receptor alpha and PR and associated with nodal status grade, and proliferation rate in breast cancer. Am J Pathol 156: 29–35, 2000
Kuiper G, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson.S, Gustafsson J: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology, 138: 863–870, 1997
Pettersson K, Gustafsson J: Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 63: 165–192, 2001
Tsai M, O'Malley B: Molecular mechanisms of action of steroid/thyroid receptor superfamily. Annu Rev Biochem 63: 451–486, 1994
Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M: Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors α and β. Cancer Res 62: 4977–4984, 2002
Po S, Chen Z, Tsang D, Leung K: Baicalein and genistein display differential actions on estrogen receptor (ER) transactivation and apoptosis in MCF-7 cells. Cancer Lett 187: 33–40, 2002
Wang X, Kilgore M: Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferatoractivated receptor gamma 1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol Cell Endocrinol 194: 123–133, 2002
Mueller-Fahrnow A, Egner U: Ligand binding domain of estrogen receptors. Curr Opin Biotech 10: 550–556, 1999
Thenot S, Charpin M, Bonnet S, Cavailles V: Estrogen receptor cofactors expression in breast and endometrial human cancer cells. Mol Cell Endocrinol 156: 85–93, 1999
Pace P, Taylor J, Sunyharalingam S, Coombes C, Ali S: Human estrogen receptor β binds DNA in a manner similar to and dimerizes with estrogen receptor α. J Biol Chem 272: 25832–25838, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Power, K.A., Thompson, L.U. Ligand-Induced Regulation of ERα and ERβ is Indicative of Human Breast Cancer Cell Proliferation. Breast Cancer Res Treat 81, 209–221 (2003). https://doi.org/10.1023/A:1026114501364
Issue Date:
DOI: https://doi.org/10.1023/A:1026114501364